These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8373321)

  • 1. Pastes, paints, lotions, liniments and dusting powders.
    Kelly BR
    Aust Fam Physician; 1993 Jul; 22(7):1286-90. PubMed ID: 8373321
    [No Abstract]   [Full Text] [Related]  

  • 2. Creams, ointments and lotions.
    Hellier FF
    Practitioner; 1969 Jan; 202(207):23-6. PubMed ID: 5777146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the prescriptions and nomenclature of dermatologic agents and in drug compounding implemented by the German Pharmacopoeia, 7th edition (DAB 7)].
    Bolle I
    Dermatol Monatsschr; 1971 Oct; 157(10):749-57. PubMed ID: 5144815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Local treatment of skin diseases].
    Roder H; Scholz A
    Dtsch Gesundheitsw; 1972 Jun; 27(26):1231-5. PubMed ID: 5076730
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescribing on the basis of subjective disease severity.
    Haverstock CL; Feldman SR
    J Dermatolog Treat; 2006; 17(5):261. PubMed ID: 17092856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subjective evaluation of some oral drug forms].
    Hüttenrauch R
    Pharm Prax; 1968; 8():197-8. PubMed ID: 5711295
    [No Abstract]   [Full Text] [Related]  

  • 7. [It must be possible to administer a prescribed drug].
    Sjöqvist M
    Lakartidningen; 1997 Oct; 94(42):3710. PubMed ID: 9411123
    [No Abstract]   [Full Text] [Related]  

  • 8. [I RPHUSE, I RMR, I treat].
    Bonnetblanc JM
    Ann Dermatol Venereol; 1997; 124(9):597-8. PubMed ID: 9739919
    [No Abstract]   [Full Text] [Related]  

  • 9. Penetration enhancers improve therapeutic effectiveness of topical immunomodulators.
    Burkhart CG; Burkhart CN
    Dermatol Online J; 2005 Dec; 11(3):39. PubMed ID: 16409935
    [No Abstract]   [Full Text] [Related]  

  • 10. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 11. Nineteenth-century patent medicines for the skin and hair.
    Albert MR
    J Am Acad Dermatol; 2000 Sep; 43(3):519-26. PubMed ID: 10954667
    [No Abstract]   [Full Text] [Related]  

  • 12. Rising drug costs: the impact on dermatology.
    Rico MJ
    Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Question of the Month. How do you prescribe the quantity of topical corticoids to be used?].
    Crickx B
    Ann Dermatol Venereol; 1999; 126(6-7):547-52. PubMed ID: 10495873
    [No Abstract]   [Full Text] [Related]  

  • 14. [Should it be possible to search original preparations via pharmacies' computers?].
    Gullberg R
    Lakartidningen; 2002 Dec; 99(49):5011. PubMed ID: 12522996
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone.
    Satyaprakash A; Balkrishnan R; Camacho FT; Jayawant SS; Fleischer AB; Feldman SR
    Arch Dermatol; 2007 Dec; 143(12):1591-2. PubMed ID: 18087018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inappropriate presentation of pharmaceutical forms of dosages in antiretroviral therapy].
    González Delgado M; Antón Torres R; Borrás Blasco J; Ortiz de Urbina Sandomingo V
    Med Clin (Barc); 1999 Oct; 113(14):559. PubMed ID: 10605679
    [No Abstract]   [Full Text] [Related]  

  • 17. Individualising therapy. The right dose, dosage form, frequency and duration.
    Shakib S; George A
    Aust Fam Physician; 2003 Jul; 32(7):504-7. PubMed ID: 12901201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosage forms of phytogenic drugs].
    Luftensteiner CP; Viernstein H
    Wien Med Wochenschr; 1999; 149(8-10):258-61. PubMed ID: 10483694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology at the start of a new millennium. Larger assortment and individual drug dosing are coming].
    Fredholm BB; Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):534-9. PubMed ID: 11475239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.